• Abe C, Iwai K, Mikami R, Hosoda Y. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl. Bakteriol. Mikrobiol. Hyg. [A] 256: 541-547 (1984).

• Alberti-Flor JJ, Jeffers L, Schiff ER. Primary sclerosing cholangitis occurring in a patient with systemic lupus erythematosus and diabetes mellitus. Am. J. Gastroenterol. 79: 889-891 (1984).

• Aly A, Carlson K, Johansson C, Kirstein P, Rossner S, Wallentin L. Lipoprotein abnormalities in patients with early primary biliary cirrhosis. Eur. J. Clin. Invest. 14: 155-162 (1984).

• Ament AE, Bick RJ, Miraldi FD, Haaga JR, Wiedenmann SD. Sclerosing cholangitis: cholescintigraphy with Tc-99m-labeled DISIDA. Radiology 151: 197-201 (1984). *

• Anderberg B, Andersson PA, Heuman R, Jansson L, Jorfeldt L, Rutberg H, Sjodahl R. Effect of propranolol and sclerotherapy in bleeding esophageal varices. A case report. Acta Chir. Scand. 150: 109-111 (1984).

• Andersen SP, Rask H, Stockel M, Hauge P. No liver 99Tc-tin-colloid uptake in primary sclerosing cholangitis. Acta Med. Scand. 216: 133-135 (1984).

• Arakawa Y, Kobayashi H, Ozaki T, Ariga H, Matsuo Y, Honda T, Arai T, Kurosu Y, Morita K, Konuma H, et al. Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation. Gan. To. Kagaku. Ryoho. 11: 917-925 (1984).

• Austin CA, Cann PA, Jones TH, Holdsworth CD. Exacerbation of diarrhoea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis. Lancet 1: 917-918 (1984).

• Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 2: 1009-1013 (1984).

• Barna JC, Williams DH. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu. Rev. Microbiol. 38: 339-357 (1984). *

• Barret L, Faure J, Guilland B, Chomat D, Didier B, Debru JL. Trichloroethylene occupational exposure: elements for better prevention. Int. Arch. Occup. Environ. Health 53: 283-289 (1984).

• Baruch Y, Brook JG, Eidelman S, Aviram M. Increased concentration of high density lipoprotein in plasma and decreased platelet aggregation in primary biliary cirrhosis. Atherosclerosis 53: 151-162 (1984).

• Becker M, von Bergmann K, Rotthauwe HW, Leiss O. Biliary lipid metabolism in children with chronic intrahepatic cholestasis. Eur. J. Pediatr. 143: 35-40 (1984).

• Beckingsale AB, Davies J, Gibson JM, Rosenthal AR. Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27. Br. J. Ophthalmol. 68: 741-745 (1984).

• Bengoa JM, Sitrin MD, Meredith S, Kelly SE, Shah N, Baker AL, Rosenberg IH. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology 4: 261-265 (1984).

• Bernstein RM, Neuberger JM, Bunn CC, Callender ME, Hughes GR, Williams R. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin. Exp. Immunol. 55: 553-560 (1984). *

• Bertrams J. The HLA association of insulin-dependent (type I) diabetes mellitus. Behring Inst. Mitt. 75: 89-99 (1984).

• Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J. Clin. Invest. 74: 1966-1971 (1984). *

• Blaser MJ, Hoverson D, Ely IG, Duncan DJ, Wang WL, Brown WR. Studies of Campylobacter jejuni in patients with inflammatory bowel disease. Gastroenterology 86: 33-38 (1984).

• Blaser MJ, Miller RA, Lacher J, Singleton JW. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 87: 888-894 (1984).

• Bodey GP. Candidiasis in cancer patients. Am. J. Med. 77: 13-19 (1984).

• Borgia G, Crowell J, Ciampi R, Nappa S, Lambiase A, Piazza M. Unusual ultrastructural findings in a case of asymptomatic primary biliary cirrhosis. Boll. Soc. Ital. Biol. Sper. 60: 249-255 (1984).

• Bories C, Certin M, Lavergne A, Galian A, Godeau P, Rambaud JC. Primary biliary cirrhosis and sarcoidosis. Association or unique disease? Gastroenterol. Clin. Biol. 8: 851-855 (1984).

• Borkje B, Odegaard S, Vetvik K, Schrumpf E. Chronic pancreatitis associated with ulcerative colitis and sclerosing cholangitis. A case report. Tidsskr. Nor. Laegeforen. 104: 585-587 (1984).

• Borsch G. The gastrointestinal tract as an immunologic organ: the gut-associated immune system. Klin. Wochenschr. 62: 699-709 (1984).

• Brennan F, O'Connor FA. Primary sclerosing cholangitis. N. Engl. J. Med. 311: 331 (1984).

• Broder S, Gallo RC. A pathogenic retrovirus (HTLV-III) linked to AIDS. N. Engl. J. Med. 311: 1292-1297 (1984).

• Bruno NP, Beacham BE, Burnett JW. Adverse effects of isotretinoin therapy. Cutis 33: 484-486, 489 (1984).

• Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfitt W, Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut 25: 133-137 (1984). *

• Butler MG, Hodes ME, Conneally PM, Biegel AA, Wright JC. Linkage analysis in a large kindred with autosomal dominant transmission of polyglandular autoimmune disease type II (Schmidt syndrome). Am. J. Med. Genet. 18: 61-65 (1984).

• Cameron JL, Gayler BW, Sanfey H, Milligan F, Kaufman S, Maddrey WC, Herlong HF. Sclerosing cholangitis. Anatomical distribution of obstructive lesions. Ann. Surg. 200: 54-60 (1984). *

• Canonica GW, Croci R, Bagnasco M, Ferrini S, Cosulich ME, Ferrini O, Giordano G. Deficiency of the autologous mixed lymphocyte reaction in patients with autoimmune thyroid disease. Int. Arch. Allergy Appl. Immunol. 73: 137-140 (1984).

• Carulli N, Loria P, Bertolotti M, Ponz de Leon M, Menozzi D, Medici G, Piccagli I. Effects of acute changes of bile acid pool composition on biliary lipid secretion. J. Clin. Invest. 74: 614-624 (1984). *

• Catsarou-Catsari A, Katsambas A, Theodoropoulos P, Stratigos J. Ophthalmological manifestations in patients with psoriasis. Acta Derm. Venereol. 64: 557-559 (1984).

• Chatelain B. Neutrophil functions and interactions in the inflammatory reaction. Ann. Biol. Clin. (Paris) 42: 77-85 (1984).

• Chen LY, Goldberg HI. Sclerosing cholangitis: broad spectrum of radiographic features. Gastrointest. Radiol. 9: 39-47 (1984).

• Chiodini RJ, Van Kruiningen HJ, Merkal RS, Thayer WR Jr, Coutu JA. Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. J. Clin. Microbiol. 20: 966-971 (1984). *

• Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA, Merkal RS. In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease. Antimicrob. Agents Chemother. 26: 930-932 (1984). *

• Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig. Dis. Sci. 29: 1073-1079 (1984).

• Chlumska A. Ultrastructural findings in intrahepatic bile ducts in primary biliary cirrhosis. Cesk. Patol. 20: 161-169 (1984).

• Chong SK, Grossman A, Walker-Smith JA, Rees LH. Endocrine dysfunction in children with Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 3: 529-534 (1984).

• Clerget-Darpoux F, Babron MC, Bonaiti-Pellie C. HLA-associated diseases: a new method for performing linkage analysis with other markers than HLA. Am. J. Hum. Genet. 36: 1075-1081 (1984). *

• Cohen D, Cohen O, Marcadet A, Massart C, Lathrop M, Deschamps I, Hors J, Schuller E, Dausset J. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 81: 1774-1778 (1984). *

• Cooper A, Betts JM, Pereira GR, Ziegler MM. Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition. J. Pediatr. Surg. 19: 462-466 (1984).

• Crabtree BL. Review of naltrexone, a long-acting opiate antagonist. Clin. Pharm. 3: 273-280 (1984).

• Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4: 1-8 (1984).

• Czaja AJ. Diagnosis and treatment of chronic hepatitis. Compr. Ther. 10: 58-63 (1984).

• Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin. Liver Dis. 4: 1-12 (1984).

• Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology 4: 622-627 (1984).

• Das KM, Kadono Y, Fleischner GM. Antibody-dependent cell-mediated cytotoxicity in serum samples from patients with ulcerative colitis. Relationship to disease activity and response to total colectomy. Am. J. Med. 77: 791-796 (1984).

• Davis GL, Czaja AJ, Ludwig J. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterology 87: 1222-1227 (1984).

• Davis PB, di Sant'Agnese PA. Diagnosis and treatment of cystic fibrosis. An update. Chest 85: 802-809 (1984). *

• de Jongh BM, Bruining GJ, Schreuder GM, Schuurman RK, Radder JK, van Loghem E, Meera Khan P, Hauptmann G, van Rood JJ. HLA and GM in insulin-dependent diabetes in the Netherlands: report on a combined multiplex family and population study. Hum. Immunol. 10: 5-21 (1984).

• De Weert J, Temmerman L, Kint A. Alopecia areata: a clinical study. Dermatologica 168: 224-229 (1984).

• Dew MJ, Ebden P, Kidwai NS, Lee G, Evans BK, Rhodes J. Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis. Br. J. Clin. Pharmacol. 17: 474-476 (1984).

• Dibble JB, Sheridan P, Losowsky MS. A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q. J. Med. 53: 119-134 (1984).

• Dickson ER, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis. Hepatology 4: 33S-35S (1984).

• Disney TF, Sullivan SN, Haddad RG, Lowe D, Goldbach MM. Budd-Chiari syndrome with inferior vena cava obstruction associated with systemic lupus erythematosus. J. Clin. Gastroenterol. 6: 253-256 (1984).

• Dite P, Nerad V, Klejna M, Hulek P, Fendrichova M, Vitek J, Trojanova J. Hepatobiliary impairment in inflammatory intestinal disease. Vnitr. Lek. 30: 363-366 (1984).

• Doppman JL, Girton ME. Bile duct scarring following ethanol embolization of the hepatic artery: an experimental study in monkeys. Radiology 152: 621-626 (1984). *

• Eaves ER, Korman MG. Cholestyramine induced hyperchloremic metabolic acidosis. Aust. N.Z. J. Med. 14: 670-672 (1984).

• Ebright JR, Ryan LM. Acute erosive reactive arthritis associated with Campylobacter jejuni-induced colitis. Am. J. Med. 76: 321-323 (1984).

• Egawa K, Yoshida M, Sakaino R, Kasai N. Hepatic drug-metabolizing enzyme system and endotoxin tolerance: structural requirement of LPS in induction of an early tolerance. Microbiol. Immunol. 28: 1181-1190 (1984).

• Elmgreen J, Sorensen H, Berkowicz A. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease. Acta Med. Scand. 215: 375-378 (1984).

• Epstein E, Kiechle FL, Zak B. Use of alkaline phosphatase isoenzyme analysis in the evaluation of cholestatic liver disease. Ann. Clin. Lab. Sci. 14: 292-297 (1984).

• Eriksson S, Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand. J. Gastroenterol. 19: 971-976 (1984).

• Evensen SA, Ritland S, Elgjo K, Solberg HE, Skrede S. Incorporation of precursors into sterols and proteins in liver biopsies from patients with liver disorders. Scand. J. Gastroenterol. 19: 6-13 (1984).

• Faruque SM, Kabir Y, Bashar SA. Effect of vitamin A supplementation on the serum levels of some immunoglobulins in vitamin A deficient children. Paediatr. Indones. 24: 249-253 (1984).

• Ferec C, Youinou P, Le Goff P, Miossec P, Morin JF, Pennec Y, Morin PP, Le Menn G. Significance of antinuclear anti-histone antibodies. Ann. Med. Interne. (Paris) 135: 427-430 (1984).

• Field LL, Anderson CE, Neiswanger K, Hodge SE, Spence MA, Rotter JI. Interaction of HLA and immunoglobulin antigens in type 1 (insulin-dependent) diabetes. Diabetologia 27: 504-508 (1984).

• Field LL, Goldstein A, Spence MA, Anderson CE, Rimoin DL. No evidence for linkage between an insulin-dependent diabetes mellitus-susceptibility locus and immunoglobulin loci KM or GM. Genet. Epidemiol. 1: 375-382 (1984).

• Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J. Biol. Chem. 259: 9508-9513 (1984). *

• Frei A, Zimmermann A, Weigand K. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 4: 830-834 (1984).

• Frey BM, Hugentobler T, Buhrer M, Frey FJ. Transcortin concentrations in the plasma of normal persons and patients with kidney and liver diseases. Klin. Wochenschr. 62: 936-938 (1984).

• Frezza M, Pozzato G, Chiesa L, Stramentinoli G, di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 4: 274-278 (1984).

• Fujita K, Naito S, Okabe N, Yao T. Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese. J. Clin. Lab. Immunol. 14: 99-102 (1984).

• Garrett-Laster M, Russell RM, Jacques PF. Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A. Hum. Nutr. Clin. Nutr. 38: 203-214 (1984).

• Giulidori P, Galli-Kienle M, Catto E, Stramentinoli G. Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo. J. Biol. Chem. 259: 4205-4211 (1984). *

• Gonzalez-Diaz JP, Gonzalez T, Gonzalez-Espinosa C, Gantes M, Santisteban M, Bustad S. HLA haplotypes in congenital adrenal hyperplasia (21-hydroxylase deficiency. An. Esp. Pediatr. 21: 583-586 (1984).

• Goodman DS. Overview of current knowledge of metabolism of vitamin A and carotenoids. J. Natl. Cancer Inst. 73: 1375-1379 (1984).

• Grennan DM, Dyer P, Dodds W, Read A, Haeney M, Clague R, Harris R. Clinical and immunogenetic studies in multicase rheumatoid families. Q. J. Med. 53: 479-485 (1984).

• Guillet G, Strobel M, Pradinaud R. Brazilian pemphigus in a child in French Guyana. Discussion on the clinical polymorphism and epidemiology of the disease. Ann. Dermatol. Venereol. 111: 1087-1092 (1984).

• Gupta RC, Seibold JR, Krishnan MR, Steigerwald JC. Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis. Clin. Exp. Immunol. 58: 68-76 (1984). *

• Gurantz D, Hofmann AF. Influence of bile acid structure on bile flow and biliary lipid secretion in the hamster. Am. J. Physiol. 247: G736-G748 (1984).

• Hall S, Axelsen PH, Larson DE, Bunch TW. Systemic lupus erythematosus developing in patients with primary biliary cirrhosis. Ann. Intern. Med. 100: 388-389 (1984).

• Hammarstrom L, Axelsson U, Bjorkander J, Hanson LA, Moller E, Smith CI. HLA antigens in selective IgA deficiency: distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens 24: 35-39 (1984).

• Hanaichi T, Kidokoro R, Hayashi H, Sakamoto N. Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab. Invest. 51: 592-597 (1984).

• Hardison WG, Grundy SM. Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology 87: 130-135 (1984).

• Hashmonai M, Kam I, Schramek A. The etiology of "white bile" in the biliary tree. J. Surg. Res. 37: 479-486 (1984).

• Haussler MR, Donaldson CA, Kelly MA, Mangelsdorf DJ, Bowden GT, Meinke WJ, Meyskens FL, Sidell N. Identification and quantitation of intracellular retinol and retinoic acid binding proteins in cultured cells. Biochim. Biophys. Acta 803: 54-62 (1984). *

• Heikkila M, Koistinen J, Lohman M, Koskimies S. Increased frequency of HLA-A1 and -B8 in association with total lack, but not with deficiency of serum IgA. Tissue Antigens 23: 280-283 (1984).

• Hodges P, Gee M, Grace M, Thomson AB. Vitamin and iron intake in patients with Crohn's disease. J. Am. Diet. Assoc. 84: 52-58 (1984).

• Hodges P, Sauriol D, Man SF, Reichert A, Grace M, Talbot TW, Brown N, Thomson AB. Nutrient intake of patients with cystic fibrosis. J. Am. Diet. Assoc. 84: 664-669 (1984).

• Homburger HA, Casey M, Jacob GL, Klee GG. Measurement of secretory IgA in serum by radioimmunoassay in patients with chronic nonalcoholic liver disease or carcinoma. Am. J. Clin. Pathol. 81: 569-574 (1984).

• Hubert D, Beaufils M, Meyrier A. Immunoglobulin A glomerular nephropathy associated with inflammatory colitis. Apropos of 2 cases. Presse. Med. 13: 1083-1085 (1984).

• Hutson DG, Russell E, Schiff E, Levi JJ, Jeffers L, Zeppa R. Balloon dilatation of biliary strictures through a choledochojejuno-cutaneous fistula. Ann. Surg. 199: 637-647 (1984). *

• Ilfeld D, Theodor E, Delpre G, Kuperman O. In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine. Clin. Exp. Immunol. 57: 438-442 (1984). *

• Iqbal MJ, Wilkinson ML, Williams R. Sex steroid binding patterns in primary biliary cirrhosis complicated by hepatocellular carcinoma. Br. Med. J. (Clin. Res. Ed.) 289: 459-460 (1984). *

• Jacobson G, Thoren L. Traumatic rupture of the common duct in sclerosing cholangitis. Acta Chir. Scand. 150: 187-189 (1984).

• Jansen PL, Cuypers HT, Peters WH. Quantitation of bilirubin conjugates with high-performance liquid chromatography in patients with low total serum bilirubin levels. Eur. J. Clin. Invest. 14: 295-300 (1984).

• Janssens AR, Bosman FT, Ruiter DJ, Van den Hamer CJ. Immunohistochemical demonstration of the cytoplasmic copper-associated protein in the liver in primary biliary cirrhosis: its identification as metallothionein. Liver 4: 139-147 (1984).

• Janssens AR, Van Noord MJ, Van Hoek CJ, Ruiter DJ, Mauw BJ, Van den Hamer CJ. The lysosomal copper concentration in the liver in primary biliary cirrhosis. Liver 4: 396-401 (1984).

• Javitt NB. Bile alcohols in perspective. Hepatology 4: 974-976 (1984).

• Johnston DV, Marshall LA. Dietary fat, prostaglandins and the immune response. Prog. Food Nutr. Sci. 8: 3-25 (1984).

• Kaplan MM, Gandolfo JV, Quaroni EG. An enzyme-linked immunosorbent assay (ELISA) for detecting antimitochondrial antibody. Hepatology 4: 727-730 (1984).

• Karlsson-Parra A, Nyberg A, Totterman TH, Loof L, Forsum U. Primary biliary cirrhosis - phenotypic characterization of immunocompetent cells in peripheral blood and liver tissue. Ups. J. Med. Sci. 89: 254-265 (1984).

• Keighley MR. Infection and the use of antibiotics in Crohn's disease. Can. J. Surg. 27: 438-441 (1984).

• Kenna JG, Neuberger J, Davies E, Eddleston AL, Williams R. A simple enzyme-linked immunosorbent assay for detection of anti-mitochondrial antibodies. J. Immunol. Methods 73: 401-413 (1984).

• Kirkinen P, Ylostalo P, Heikkinen J, Maentausta O. Gallbladder function and maternal bile acids in intrahepatic cholestasis of pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 18: 29-34 (1984).

• Kirkpatrick RB, Kraft BG. Effect of streptozotocin-induced diabetes on bile acid sulfation in male rat liver. Am. J. Physiol. 247: G226-G230 (1984). *

• Kluge F, Hoppe-Seyler P, Gerok W. Immunogenetic findings in Crohn disease, ulcerative colitis and gluten sensitive enteropathy. Z. Gastroenterol. 22: 277-284 (1984).

• Krom RA, Gips CH, Houthoff HJ, Newton D, van der Waaij D, Beelen J, Haagsma EB, Slooff MJ. Orthotopic liver transplantation in Groningen, The Netherlands (1979-1983). Hepatology 4: 61S-65S (1984).

• Kurki P, Gripenberg M, Teppo AM, Salaspuro M. Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver 4: 134-138 (1984).

• LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Current concepts. Primary sclerosing cholangitis. N. Engl. J. Med. 310: 899-903 (1984).

• Leont'ev AF, Pugachev AG, Seniakovich VM, Tuichibekov ShM, Chistova LV. Results of the surgical treatment of fibrocholangiocystosis of the liver in children. Vestn. Khir. Im. I. I. Grek. 133: 96-99 (1984).

• Levy DM, Sagar HJ. Herpes simplex type 2 meningitis treated with acyclovir. Postgrad. Med. J. 60: 282-283 (1984). *

• Lieber CS. Metabolism and metabolic effects of alcohol. Med. Clin. North Am. 68: 3-31 (1984).

• Lieberman DA, Keeffe EB, Stenzel P. Severe and prolonged oral contraceptive jaundice. J. Clin. Gastroenterol. 6: 145-148 (1984).

• Lindgren S, Laurell AB, Eriksson S. Complement components and activation in primary biliary cirrhosis. Hepatology 4: 9-14 (1984).

• Lindgren S, McKay J, Hansson I, Eriksson S. Evidence of increased intestinal synthesis and extracellular deposition of IgM in primary biliary cirrhosis. An immunofluorescence study of liver and small-intestinal biopsy specimens. Scand. J. Gastroenterol. 19: 97-104 (1984).

• Lindor KD, Malagelada JR. Symposium on upper gastrointestinal motility disorders. Gastric motor disorders: an overview. South. Med. J. 77: 943-946 (1984).

• Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver 4: 105-116 (1984).

• Machin ND, Chard MD, Paice EW. Serum angiotensin converting enzyme in Sjogren's syndrome - a case report and study of 21 further cases. Postgrad. Med. J. 60: 270-271 (1984). *

• MacLean CA, Goudie BM, MacSween RN, Sandilands GP. Serum Fc gamma-receptor-like molecules in primary biliary cirrhosis: a possible immunoregulatory mechanism. Immunology 53: 315-324 (1984). *

• MacLeod CM, Bartley EA, Payne JA, Hudes E, Vernam K, Devlin RG. Effects of cirrhosis on kinetics of aztreonam. Antimicrob. Agents Chemother. 26: 493-497 (1984).

• Maeda N, Yang F, Barnett DR, Bowman BH, Smithies O. Duplication within the haptoglobin Hp2 gene. Nature 309: 131-135 (1984).

• Maier KP. Therapy of chronic non-A, non-B hepatitis. Leber. Magen. Darm. 14: 232-235 (1984).

• Malvaldi G, Chieli E, Saviozzi M. Biliary cirrhosis and tumors induced by chronic administration of thiobenzamide to rats. Arch. Toxicol. 55: 34-38 (1984).

• Manns M, Meyer zum Buschenfelde KH, Slusarczyk J, Dienes HP. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases. Clin. Exp. Immunol. 57: 600-608 (1984). *

• Marcus AJ. The eicosanoids in biology and medicine. J. Lipid Res. 25: 1511-1516 (1984). *

• Marcus SN, Chadwick D, Walker RJ. D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis. Gastroenterology 86: 166-168 (1984).

• Martin DM, Vroon DH, Nasrallah SM. Value of serum immunoglobulins in the diagnosis of liver disease. Liver 4: 214-218 (1984).

• Martin EC, Fankuchen EI, Laffey KJ, Sibley RE. Percutaneous management of benign biliary disease. Gastrointest. Radiol. 9: 207-212 (1984).

• Matsui Y, Alosco SM, Awdeh Z, Duquesnoy RJ, Page PL, Hartzman RJ, Alper CA, Yunis EJ. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes. Immunogenetics 20: 623-631 (1984).

• Matsuoka LY, Wortsman J, Pepper JJ. Acute arthritis during isotretinoin treatment for acne. Arch. Intern. Med. 144: 1870-1871 (1984).

• Matsuyama SS, Joseph J. Haptoglobin types and unipolar depression. Hum. Hered. 34: 65-68 (1984).

• McClusky OE, Lordon RE, Arnett FC Jr. HL-A 27 in Reiter's syndrome and psoriatic arthritis: a genetic factor in disease susceptibility and expression. J. Rheumatol. 11: 571 (1984).

• McCullough AJ, Czaja AJ. Relapse following treatment withdrawal in autoimmune chronic active hepatitis. Hepatology 4: 747-748 (1984).

• McGhee JR, Michalek SM, Kiyono H, Eldridge JH, Colwell DE, Williamson SI, Wannemuehler MJ, Jirillo E, Mosteller LM, Spalding DM, et al. Mucosal immunoregulation: environmental lipopolysaccharide and GALT T lymphocytes regulate the IgA response. Microbiol. Immunol. 28: 261-280 (1984).

• McIntyre PB, Lennard-Jones JE. Reversal with balsalazide of infertility caused by sulphsalazine. Br. Med. J. (Clin. Res. Ed.) 288: 1652-1653 (1984). *

• Melia WM, Johnson PJ, Neuberger J, Zaman S, Portmann BC, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Gastroenterology 87: 660-663 (1984).

• Mielants H, Veys EM, Cuvelier C, De Vos M. Macroscopic and histological changes of the ileum HLA-B27 related diseases: therapeutic consequences. Int. J. Clin. Pharmacol. Res. 4: 409-414 (1984).

• Mihas AA, Volanakis JE, Schrohenloher RE, Mihas TA. Circulating immune complexes in primary sclerosing cholangitis. Hepatology 4: 351-352 (1984).

• Miller KB, Elta GH, Rudders RA, Kaplan MM. Lymphocyte subsets in primary biliary cirrhosis. Ann. Intern. Med. 100: 385-387 (1984).

• Miller MM. Ankylosing spondylitis, Reiter's syndrome, psoriatic arthritis, and arthritis of inflammatory bowel disease. Prim. Care 11: 271-282 (1984).

• Miro I, Bakir R, Chanu B, Brocheriou C, Brenot F, Rouffy J. Riedel's thyroiditis and retroperitoneal fibrosis. Apropos of a case of multiple fibrosing disease. Ann. Med. Interne. (Paris) 135: 212-216 (1984).

• Mitamura T. Alterations of high density lipoproteins in experimental intrahepatic cholestasis in the rat induced by administration of alpha-naphthylisothiocyanate. J. Biochem. 95: 29-36 (1984).

• Mittal KK. Immunobiology of the human major histocompatibility complex: association of HLA antigens with disease. Acta Anthropogenet. 8: 245-268 (1984).

• Miyachi K, Watanabe S, Yamashiki M, Hiwatashi T, Ichida F. Precipitating antimitochondrial antibodies in Japanese patients with primary biliary cirrhosis. Am. J. Gastroenterol. 79: 704-709 (1984).

• Mobacken H, Nilsson LA, Olsson R, Sloberg K. Incidence of liver disease in chronic lichen planus of the mouth. Acta Derm. Venereol. 64: 70-73 (1984).

• Molina Jurado M, Ferrer J, Gomez N. Primary sclerosing cholangitis. Acta Gastroenterol. Latinoam. 14: 225-228 (1984).

• Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex. Am. J. Surg. 147: 822-826 (1984).

• Montgomery EH, Kroeger DC. Use of antibiotics in dental practice. Dent. Clin. North Am. 28: 433-453 (1984).

• Nakagaki M, Danzinger RG, Hofmann AF, DiPietro RA. Biliary secretion and hepatic metabolism of taurine-conjugated 7 alpha-hydroxy and 7 beta-hydroxy bile acids in the dog. Defective hepatic transport and bile hyposecretion. Gastroenterology 87: 647-659 (1984).

• Nasu M, Matsubara O, Kamiyama R, Yamada T, Nishido T, Yamato H. Gastric plasmacytoma and multisystem autoimmune disease. Virchows Arch. A. Pathol. Anat. Histopathol. 404: 109-115 (1984).

• Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand. J. Gastroenterol. 19: 724-732 (1984).

• Novick NL, Lawson W, Schwartz IS. Bilateral nasal bone osteophytosis associated with short-term oral isotretinoin therapy for cystic acne vulgaris. Am. J. Med. 77: 736-739 (1984).

• Nyhlin H, Brydon G, Danielsson A, Westman S. Clinical application of a selenium (75Se)-labelled bile acid for the investigation of terminal ileal function. Hepatogastroenterology 31: 187-191 (1984).

• O'Grady JG, Stevens FM, Keane R, Cryan EM, Egan-Mitchell B, McNicholl B, McCarthy CF, Fottrell PF. Intestinal lactase, sucrase, and alkaline phosphatase in 373 patients with coeliac disease. J. Clin. Pathol. 37: 298-301 (1984). *

• O'Morain C, Smethurst P, Dore CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 25: 1078-1084 (1984). *

• Okano Y, Nishikai M, Sato A. Scleroderma, primary biliary cirrhosis, and Sjogren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann. Rheum. Dis. 43: 520-522 (1984). *

• Okuda H, Obata H, Nakanishi T, Hisamitsu T, Matsubara K, Watanabe H. Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography. Hepatogastroenterology 31: 168-171 (1984).

• Ostrowski J, Kosecki P, Martynska M, Milewski B. Urinary porphyrins in liver disease. Scand. J. Gastroenterol. 19: 862-866 (1984).

• Owen JS, Goodall H, Mistry P, Harry DS, Day RC, McIntyre N. Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts. J. Lipid Res. 25: 919-931 (1984). *

• Oxelius VA. Immunoglobulin G (IgG) subclasses and human disease. Am. J. Med. 76: 7-18 (1984).

• Palmer KR, Cotton PB, Chapman M. Pancreatogram in cholestasis. Gut 25: 424-427 (1984). *

• Pang JA, Vicary FR. Carcinoma of the colon, sclerosing cholangitis, pericholangitis, and bronchiectasis in a patient with chronic ulcerative colitis. J. Clin. Gastroenterol. 6: 361-363 (1984).

• Pariente EA. Primary sclerosing cholangitis. Rev. Prat. 34: 2841-2847 (1984).

• Pattinson NR, Chapman BA. Lithocholate detoxification and biliary secretion in the rat. Biochem. Int. 9: 137-142 (1984).

• Peppercorn MA. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development. Ann. Intern. Med. 101: 377-386 (1984).

• Perkins HA. IgA deficiency. Immunohematology 1: 9-11 (1984).

• Pincon JA, Chatelain P, Mallet-Guy Y, Bouvier R, de Parscau L, Francois R. Byler's disease. Ultrastructural study. Apropos of a case in an infant. Pediatrie. 39: 279-288 (1984).

• Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum and sarcoidosis. Arch. Dermatol. 120: 959-960 (1984).

• Powell FC, Winkelmann RK, Venencie-Lemarchand F, Spurbeck JL, Schroeter AL. The anticentromere antibody: disease specificity and clinical significance. Mayo Clin. Proc. 59: 700-706 (1984).

• Poynard T, Zourabichvili O, Hilpert G, Naveau S, Poitrine A, Benatar C, Chaput JC. Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients. Hepatology 4: 324-327 (1984).

• Prendergast JK, McGuigan LE, Geczy AF, Kwong TS, Edmonds JP. Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis. Infect. Immun. 46: 686-689 (1984).

• Qualman SJ, Haupt HM, Bauer TW, Taxy JB. Adenocarcinoma of the hepatic duct junction. A reappraisal of the histologic criteria of malignancy. Cancer 53: 1545-1551 (1984).

• Raper R, Ibels L, Lauer C, Barnes P, Lunzer M. Fulminant hepatic failure due to allopurinol. Aust. N. Z. J. Med. 14: 63-65 (1984).

• Rautio A. Liver function and medroxyprogesterone acetate elimination in man. Biomed. Pharmacother. 38: 199-204 (1984).

• Rawcliffe PM, Giles P, Bartlett S, Jewell DP, Ross BD. Carnitine as a possible adjunct in parenteral feeding. Clin. Nutr. 3: 141-145 (1984).

• Rayment C, Geczy AF, Bashir HV, Edmonds JP. A factor in the culture filtrate of some Klebsiella isolates specifically modifies the fibroblasts of HLA-B27-positive normal individuals. Immunology 52: 385-387 (1984). *

• Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 2: 493-495 (1984).

• Redinger RN, Hawkins JW, Grace DM. The economy of the enterohepatic circulation of bile acids in the baboon. 1. Studies of controlled enterohepatic circulation of bile acids. J. Lipid Res. 25: 428-436 (1984). *

• Reynolds JR, Bourke JB. Primary sclerosing cholangitis in an 82-year old man. Br. J. Clin. Pract. 8: 278-279 (1984).

• Ricci OE, Tozzi P, Caldini M, Pasquinelli IT, Orsini B, Ventura L, Borsotti M, Surrenti C. Serum alkaline phosphatase isoenzymes: the fast liver fraction in the diagnosis of hepatobiliary disease with or without cholestasis. Boll. Soc. Ital. Biol. Sper. 60: 1363-1368 (1984).

• Rich SS, Weitkamp LR, Barbosa J. Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes. Am. J. Hum. Genet. 36: 1015-1023 (1984). *

• Rittner C, DeMarchi M, Mollenhauer E, Carbonara A. Coeliac disease and C4A*QO: an association secondary to HLA-DR3. Tissue Antigens 23: 130-134 (1984).

• Robson S, Neuberger J, Keller HP, Abisch E, Neiderberger W, von Graffenried B, Williams R. Pharmacokinetic study of cyclosporin A (Sandimmun) in patients with primary biliary cirrhosis. Br. J. Clin. Pharmacol. 18: 627-631 (1984).

• Ros E, Garcia-Puges A, Reixach M, Cuso E, Rodes J. Fat digestion and exocrine pancreatic function in primary biliary cirrhosis. Gastroenterology 87: 180-187 (1984).

• Rosenberg IH, Bowman BB. Impact of intestinal parasites on digestive function in humans. Fed. Proc. 43: 246-250 (1984).

• Rosenstein IJ, Hazlehurst GR, Burroughs AK, Epstein O, Sherlock S, Brumfitt W. Recurrent bacteriuria and primary biliary cirrhosis: ABO blood group, P1 blood group, and secretor status. J. Clin. Pathol. 37: 1055-1058 (1984). *

• Rubel LR, Rabin L, Seeff LB, Licht H, Cuccherini BA. Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology 4: 671-677 (1984).

• Rubel LR, Seeff LB, Patel V. Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome. Arch. Pathol. Lab. Med. 108: 360-361 (1984).

• Salyers AA. Bacteroides of the human lower intestinal tract. Annu. Rev. Microbiol. 38: 293-313 (1984). *

• Sauerbruch T. Endoscopic retrograde cholangiography in the diagnosis of liver diseases. Z. Gastroenterol. 22: 21-29 (1984).

• Scharschmidt BF. Human liver transplantation: analysis of data on 540 patients from four centers. Hepatology 4: 95S-101S (1984).

• Schernthaner G, Mayr WR. Immunoglobulin allotype markers and HLA DR genes in type I diabetes mellitus. Metabolism 33: 833-836 (1984).

• Schoeman M, Bezuidenhout DJ. Folate levels in patients with ulcerative colitis receiving sulphasalazine. S. Afr. Med. J. 66: 415 (1984).

• Scholmerich J, Wietholtz H, Buchsel R, Kottgen E, Lohle E, Gerok W. Zinc and vitamin A deficiency in gastrointestinal diseases. Leber. Magen. Darm. 14: 288-295 (1984).

• Schultheiss HP, Berg PA, Klingenberg M. Inhibition of the adenine nucleotide translocator by organ specific autoantibodies in primary biliary cirrhosis. Clin. Exp. Immunol. 58: 596-602 (1984). *

• Shaffer JL, Hughes S, Linaker BD, Baker RD, Turnberg LA. Controlled trial of rifampicin and ethambutol in Crohn's disease. Gut 25: 203-205 (1984). *

• Shepherd AN, Bedford GJ, Hill A, Bouchier IA. Primary biliary cirrhosis, dark adaptometry, electro-oculography, and vitamin A state. Br. Med. J. (Clin. Res. Ed.) 289: 1484-1485 (1984). *

• Shichiri M, Koyama W, Tozuka S, Sakamoto S, Kanayama M. Primary biliary cirrhosis. A patient with adverse reactions to tiopronin and autoimmune hemolytic anemia with reticulocytopenia. Arch. Intern. Med. 144: 89-91 (1984).

• Si L, Whiteside TL, Schade RR, Starzl TE, Van Thiel DH. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J. Clin. Immunol. 4: 262-272 (1984).

• Si L, Whiteside TL, Van Thiel DH, Rabin BS. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients. Lab. Invest. 50: 341-347 (1984).

• Singhal AK, Cohen BI, Finver-Sadowsky J, McSherry CK, Mosbach EH. Role of hydrophilic bile acids and of sterols on cholelithiasis in the hamster. J. Lipid Res. 25: 564-570 (1984). *

• Snover DC, Weisdorf SA, Ramsay NK, McGlave P, Kersey JH. Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology 4: 123-130 (1984).

• Sokol RJ, Heubi JE, Iannaccone ST, Bove KE, Balistreri WF. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. N. Engl. J. Med. 310: 1209-1212 (1984).

• Soule JC, Delchier JC, Zittoun J, Pariente E, Blanchi A, Boubaker AT, Chaumette MT. Functional, morphological and biochemical study of the jejunal mucosa in cryptogenetic colitis. Gastroenterol. Clin. Biol. 8: 800-807 (1984).

• Spence RA, Anderson JR, Johnston GW, Fulton TT, Callender ME. Primary sclerosing cholangitis. Ulster Med. J. 53: 44-50 (1984).

• Steckman M, Drossman DA, Lesesne HR. Hepatobiliary disease that precedes ulcerative colitis. J. Clin. Gastroenterol. 6: 425-428 (1984).

• Steeno OP. Side-effects of salazopyrin on male fertility. Eur. J. Obstet. Gynecol. Reprod. Biol. 18: 361-364 (1984).

• Stewart ME, Benoit AM, Downing DT, Strauss JS. Suppression of sebum secretion with 13-cis-retinoic acid: effect on individual skin surface lipids and implications for their anatomic origin. J. Invest. Dermatol. 82: 74-78 (1984). *

• Stiehl A, Raedsch R, Rudolph G, Walker S. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients. Hepatology 4: 107-111 (1984).

• Stigendal L, Olsson R, Rydberg L, Samuelsson BE. Blood group Lewis phenotype on erythrocytes and in saliva in alcoholic pancreatitis and chronic liver disease. J. Clin. Pathol. 37: 778-782 (1984). *

• Strange RC. Hepatic bile flow. Physiol. Rev. 64: 1055-1102 (1984).

• Stringel G, Mercer S, Sharpe D, Shipman R, Jimenez C. Eosinophilic gastroenteritis. Can. J. Surg. 27: 182-183 (1984).

• Takikawa H, Beppu T, Seyama Y. Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases. Gastroenterol. Jpn. 19: 104-109 (1984).

• Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 86: 1421-1427 (1984).

• Tazawa Y, Yamada M, Nakagawa M, Konno T, Tada K. Serum bile acid patterns determined by an enzymatic method and high-performance liquid chromatography in young infants with cholestasis. J. Pediatr. Gastroenterol. Nutr. 3: 394-401 (1984).

• Teres J, Gomez-Moli J, Bruguera M, Visa J, Bordas JM, Pera C. Sclerosing cholangitis after surgical treatment of hepatic echinococcal cysts. Report of three cases. Am. J. Surg. 148: 694-697 (1984).

• Terkeltaub R, Esdaile JM, Bruneau C, Danoff D, Watters AK. Vasculitis as a presenting manifestation of primary biliary cirrhosis: a case report. Clin. Exp. Rheumatol. 2: 67-73 (1984).

• Thayer WR Jr, Coutu JA, Chiodini RJ, Van Kruiningen HJ, Merkal RS. Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease. Dig. Dis. Sci. 29: 1080-1055 (1984).

• Thompson HH, Pitt HA, Lewin KJ, Longmire WP Jr. Sclerosing cholangitis and histiocytosis X. Gut 25: 526-530 (1984). *

• Thomsen P, Vasehus Madsen P, Moesgaard F, Lykkegaard Nielsen MC. Biliary cystadenoma of the common bile duct with secondary biliary cirrhosis. Report of a case. Acta Med. Scand. 216: 327-330 (1984).

• Triger DR, Berg PA, Rodes J. Epidemiology of primary biliary cirrhosis. Liver 4: 195-200 (1984).

• Trnka YM, Lamont JT. Clostridium difficile colitis. Adv. Intern. Med. 29: 85-107 (1984).

• Tseng J. A population of resting IgM-IgD double-bearing lymphocytes in Peyer's patches: the major precursor cells for IgA plasma cells in the gut lamina propria. J. Immunol. 132: 2730-2735 (1984).

• Tsuda H, Masui T, Imaida K, Fukushima S, Ito N. Promotive effect of primary and secondary bile acids on the induction of gamma-glutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats. Gann. 75: 871-875 (1984).

• Utley RJ, Angus HB, Macbeth WA. Primary sclerosing cholangitis. N. Z. Med. J. 97: 324-326 (1984).

• Uzoegwu P, Baum H, Williamson J. Correlation of oligomycin-sensitive ATPase activity in trypanosomes with their content of an antigen to primary biliary cirrhosis. Cell Biol. Int. Rep. 8: 981-986 (1984).

• Uzoegwu PN, Baum H, Williamson J. Detection of an antigen to primary biliary cirrhosis in wild type and petite mutant Saccharomyces cerevisiae. Cell Biol. Int. Rep. 8: 987-992 (1984).

• van den Oord JJ, Fevery J, de Groote J, Desmet VJ. Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis. Liver 4: 264-274 (1984).

• van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 27: 241-249 (1984).

• Van Spreeuwel JP, Van Gorp LH, Nadorp JH, Janssens AR, Lindeman J, Meijer CJ. Immunoglobulin-containing cells in liver biopsies of patients with chronic hepatitis and primary biliary cirrhosis. Histopathology 8: 559-566 (1984).

• Vinciullo C. Allopurinol hypersensitivity. Med. J. Aust. 141: 449-450 (1984).

• Vinciullo C. Allopurinol hypersensitivity: a potentially life threatening reaction. Australas. J. Dermatol. 25: 59-67 (1984).

• von Bergmann K, Epple-Gutsfeld M, Leiss O. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology 87: 136-143 (1984).

• Vyberg M, Poulsen H. Abnormal bile duct epithelium accompanying septicaemia. Virchows Arch. A. Pathol. Anat. Histopathol. 402: 451-458 (1984).

• Walt RP, Kemp CM, Lyness L, Bird AC, Sherlock S. Vitamin A treatment for night blindness in primary biliary cirrhosis. Br. Med. J. (Clin. Res. Ed.) 288: 1030-1031 (1984). *

• Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs 27: 95-131 (1984).

• Watanakunakorn C. Mode of action and in-vitro activity of vancomycin. J. Antimicrob. Chemother. 14 Suppl. D: 7-18 (1984).

• Weber RS, Jenkins HA, Coker NJ. Sensorineural hearing loss associated with ulcerative colitis. A case report. Arch. Otolaryngol. 110: 810-812 (1984).

• Weigand K, Zaugg PY, Frei A, Zimmermann A. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease. Hepatology 4: 835-838 (1984).

• Weiss J, Muello K, Victor M, Elsbach P. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J. Immunol. 132: 3109-3115 (1984).

• White L, McCoy R, Tait B, Ebringer R. A search for Gram-negative enteric micro-organisms in acute anterior uveitis: association of Klebsiella with recent onset of disease, HLA-B27, and B7 CREG. Br. J. Ophthalmol. 68: 750-755 (1984). *

• White R. Looking for epilepsy genes. Ann. Neurol. 16: S12-S17 (1984).

• Wiedmann KH, Bartholemew TC, Brown DJ, Thomas HC. Liver membrane antibodies detected by immunoradiometric assay in acute and chronic virus-induced and autoimmune liver disease. Hepatology 4: 199-204 (1984).

• Wijsman EM. Techniques for estimating genetic admixture and applications to the problem of the origin of the Icelanders and the Ashkenazi Jews. Hum. Genet. 67: 441-448 (1984).

• Wilders MM, Drexhage HA, Kokje M, Verspaget HW, Meuwissen SG. Peripolesis followed by cytotoxicity in chronic idiopathic inflammatory bowel disease. Clin. Exp. Immunol. 57: 614-620 (1984). *

• Wills MR, Savory J. Vitamin D metabolism and chronic liver disease. Ann. Clin. Lab. Sci. 14: 189-197 (1984).

• Wiltbank T. IgA deficiency. Immunohematology 1: 8-9 (1984).

• Wolke AM, Schaffner F, Kapelman B, Sacks HS. Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women. Am. J. Med. 76: 1075-1078 (1984).

• Yousif-Kadaru AG, Rajkovic IA, Wyke RJ, Williams R. Defects in serum attractant activity in different types of chronic liver disease. Gut 25: 79-84 (1984). *

• Zanbilowicz J. Ultrasound diagnosis of sclerosing cholangitis. J. Can. Assoc. Radiol. 35: 183-185 (1984).

• Zauli D, Fusconi M, Crespi C, Bianchi FB, Pisi E. A simple method for purification of human monocytes and evaluation of IgG Fc-receptor-mediated phagocytosis. Ric. Clin. Lab. 14: 635-639 (1984).

• Zawie DA, Garvey MS. Feline hepatic disease. Vet. Clin. North Am. Small Anim. Pract. 14: 1201-1230 (1984).

• Zegarelli DJ. Treatment of oral lichen planus with topical vitamin A acid. J. Oral Med. 39: 186-191 (1984).

• Zeitlhofer J, Mamoli B, Dragosics B, Knoflach P. Electrophysiological studies in primary biliary cirrhosis. Eur. Neurol. 23: 247-251 (1984).

• Zoltowska A, Boj E, Kryszewski A, Zamorska B. Idiopathic ulcerative colitis and chronic catarrhal colitis in the light of immunomorphological studies. Patol. Pol. 35: 435-444 (1984).

• Zseli J, Csillag J, Tulassay Z, Tarjan G, Moksony I. Gonadotropin-secreting liver cancer in ulcerative colitis. Wien. Klin. Wochenschr. 96: 5-8 (1984).

• Zufarov KA, Khidoiatov BA, Sadriddinov AF. Morphogenesis of intralobular liver fibrosis in obstructive jaundice patients. Arkh. Patol. 46: 51-57 (1984).

Number of references = 262

www psc-literature.org